TCL Archive In Brief: Increased Output Can Hold Down High Let Cost, Kligerman says; No More Groups On The Block March 18, 1977
TCL Archive Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival December 28, 2012
TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program October 25, 1985